Valuation: OrganiGram Holdings Inc

Market Cap 182M 130M 113M 105M 96.41M 12.37B 185M 1.24B 485M 6.15B 487M 476M 20.67B P/E 2026 *
10.1x
P/E 2027 * 34.4x
Enterprise Value 182M 130M 113M 105M 96.41M 12.37B 185M 1.24B 485M 6.15B 487M 476M 20.67B EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.42x
Free-Float
69.74%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 14/01/2026
Director of Finance/CFO - 07/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 28/03/2018
Director/Board Member 56 16/12/2018
Director/Board Member 70 16/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
-1.06%-9.65% - - 129M
+3.05%+3.85%+47.81%+221.53% 225M
-1.60%-0.54%-1.07%+85.00% 132M
0.00%-3.61%-14.89%-35.48% 81.19M
+8.80%+3.12%-27.58%-13.83% 75.91M
Average +1.84%-4.38%+1.07%+64.30% 128.37M
Weighted average by Cap. +1.57%-2.88%+14.20%+111.05%

Financials

2026 *2027 *
Net sales 336M 240M 208M 194M 178M 22.91B 342M 2.29B 897M 11.38B 901M 881M 38.26B 436M 311M 271M 251M 232M 29.74B 444M 2.97B 1.16B 14.77B 1.17B 1.14B 49.67B
Net income 18.08M 12.9M 11.2M 10.4M 9.6M 1.23B 18.4M 123M 48.23M 612M 48.44M 47.38M 2.06B 4M 2.85M 2.48M 2.3M 2.12M 273M 4.07M 27.26M 10.67M 135M 10.72M 10.49M 455M
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-